Pete, the photo is a "black" ball. Re:timing.... this is my opinion/guess. Means ABSOLUTELY nothing! Things are always 6-9 months behind schedule. Which in the biopharma world is actually very good. We get CTIX Ph 1 results from DF toward end of year, so I am figuring Phase 2 won't start until first quarter of 2014 (maybe a little sooner) . . . then another 12 months. Obviously lots of Prurisol stuff happening, other Kevetrin trials starting, news, news, news . . . and yes, a buyout offer could come at any time. But, if things go as Leo plans and he wants to holdout to maximize value between Ph2-Ph3 Kevetrin trials, then I see that 2 years out plus or minus 6 months. I have lots of patience and confidence in the CTIX team.